Cargando…
Defining Minimum Essential Factors to Derive Highly Pure Human Endothelial Cells from iPS/ES Cells in an Animal Substance-Free System
It is desirable to obtain unlimited supplies of endothelial cells for research and therapeutics. However, current methods of deriving endothelial cells from humans suffer from issues, such as limited supplies, contamination from animal substances, and lengthy/complicated procedures. In this article...
Autores principales: | Wu, Yu-Ting, I.-Shing Yu, Tsai, Kuen-Jer, Shih, Chien-Yu, Hwang, Shiaw-Min, Su, Ih-Jen, Chiang, Po-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394195/ https://www.ncbi.nlm.nih.gov/pubmed/25864432 http://dx.doi.org/10.1038/srep09718 |
Ejemplares similares
-
The Promise and Therapeutic Potential of Human ES and iPS Cells
por: Lu, Shi-Jiang, et al.
Publicado: (2011) -
An Improved Technique for Chromosomal Analysis of Human ES and iPS Cells
por: Moralli, Daniela, et al.
Publicado: (2010) -
Genetic engineering of human ES and iPS cells using TALE nucleases
por: Hockemeyer, Dirk, et al.
Publicado: (2011) -
Cyclic GMP signalling in human ES and iPS-derived vascular cells
por: Taura, Daisuke, et al.
Publicado: (2009) -
An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells
por: Di Stefano, Bruno, et al.
Publicado: (2010)